Control Bionics (ASX:CBL)
ASX announcement history & article coverage
Transparent by design.
Announcments by Control Bionics (ASX:CBL) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Cleansing notice
Change of Director's Interest Notice - Rix
Application for quotation of securities - CBL
Change of Director's Interest Notice - Steele
Notification regarding unquoted securities - CBL
Results of 2026 AGM
2026 AGM Presentation
Notification of cessation of securities - CBL
NeuroStrip CE Marked for Sale Across Europe
Breach of Listing Rule 10.1
German distribution agreement - Tobii Dynavox
Shareholder letter - 2026 AGM
Notice of Annual General Meeting/Proxy Form
Notification regarding unquoted securities - CBL
Change of Director's Interest Notice - Rix
2026 Results Commentary
Appendix 4G
Corporate Governance Statement
2026 Annual Report
Control Bionics reports FY26 results with strategic pivot, $7.27M loss, $15M capital raised, and growth initiatives underway
Preliminary Final Report
Control Bionics reports lower revenue, increased loss, and full acquisition of Neuro Elite Athletics
FY26 Results Investor Webcast Notification
Medicare Billing Code Secured for NextLevel Speech Devices
Control Bionics Secures US Medicare Coding for UnoTouch Omni Devices, US Sales to Begin September 2026
NeuroStrip secures MHRA registration
Control Bionics secures UK MHRA registration for NeuroStrip, begins early trials
Notification regarding unquoted securities - CBL
Change in substantial holding - Nightingale
Change in substantial holding - Phoenix
Change of Director's Interest Notice - Steele
Change of Director's Interest Notice - Opie
Change of Director's Interest Notice - Heard
Change of Director's Interest Notice - Lismore
Change of Director's Interest Notice - Rix
Cleansing notice
Application for quotation of securities - CBL
NeuroStrip App Launch on Apple and Microsoft Stores
Notification regarding unquoted securities - CBL
Results of Meeting
US FDA Registration and Device Listing for NeuroStrip
Control Bionics secures FDA registration for NeuroStrip™ medical device
Commercial momentum builds across both platform pillars
Control Bionics advances commercial scale with NextLevel tablets shipped and NeuroStrip expanded to 20 organisations
Quarterly Activities/Appendix 4C Cash Flow Report
Control Bionics advances capital raise and commercial growth despite near-term revenue headwinds
Change of Director's Interest Notice - Rix
Application for quotation of securities - CBL
SPP results
Control Bionics completes $256,500 Share Purchase Plan, total raise reaches $9.75 million
